RT @AAMRI_Aus: 📣 Calling Vic Early-Mid Career Researchers! We're excited to offer YOU a spot in an industry-informed commercialisation trai….

👨🏻‍🔬💡💊 @CSL was awarded a #REDI Fellowship to embed Dr Samuel Harley, a #research #translation & #commercialisation professional from @QIMRB_Institute, within its Global Research Innovation team. Find out more about his placement with CSL in 🇦🇺🏖️ & 🇨🇭🌄

👁️👨‍💻👩‍⚕️@ellexmedical - a leading ophthalmic equipment manufacturer - was awarded a #REDI Fellowship for A/Prof Ivan Lee from @UniversitySA STEM to address challenges in image processing in the development of a new device for glaucoma treatment. Read more

.@QUT's Cardiovascular Engineering Lab has developed a new way to diagnose clogged arteries in people with diabetes & heart disease. Find out why funding from our Targeted Translation Research Accelerator #TTRA program was crucial for this project. 💡💰❤️💻

Each year over our #REDI initiative, 20 pharma & medtech researchers, clinicians & innovators from around 🇦🇺 were awarded short-term industry placements via @redi_qut Bridge & BridgeTech Industry Fellowships to increase skills & knowledge. Find out more.

📢ICYMI! Our TTRA Drugs & Devices accelerator funding opportunity closed 4 Nov, we wrapped up our North America medtech mission w special podcast, news, events & case study on @speedx & more!

📢Closing 4 Nov! EOIs for the Targeted Translation Research Accelerator (TTRA) Drugs & Devices from SMEs keen to commercialise innovative medical products to address cardiovascular disease & diabetes complications. Up to $1.5M available. @CSL @rochediaau

📢Our Oct newsletter is out! Our TTRA Drugs & Devices accelerator funding opportunity closes 4 Nov, we wrap up our North America medtech mission w special podcast, news, events & a case study on @speedx & more!

With the Korean biotech delegation in Melbourne, our @belcher_jarrod was pleased to join the group from KHIDI & Yonsei University's K-NIBRT – on a visit to @MonashUni Parkville to discuss pharmaceutical sciences, mRNA research & workforce development! 🇰🇷🇦🇺

🎧Special #MedTechConf podcast from N. America with @DMCM's Kylle Jordan, @MedicalAlley's Roberta Dressen, iYarn’s Lockie Cooke, @UniMelb's @DrLaurenAyton, Materia Health’s Dr Emily Zhen & major supporter, @Global_Vic’s Carolin McCaffrey. 🎧

🎧In our special #MedTechConf podcast ep we hear from @DMCM's Kylle Jordan, @MedicalAlley's Roberta Dressen, iYarn’s Lockie Cooke, @UniMelb's @DrLaurenAyton, Materia Health’s Dr Emily Zhen & major supporter, @Global_Vic’s Carolin McCaffrey. Stay tuned! 2/2🧵

🎧Tune into a special @MedTechCon 2024 podcast ep where our CEO @StuDignam catches up with some medtech movers & shakers during our Australian delegation’s visit to North America and find out why international connections can make the difference. 🇦🇺🌏 1/2 🧵.

Great news from @ArgenicaT 👇.

Great to see @AusBiotech CEO Rebekah Cassidy & our CEO @StuDignam Dignam at #AusBiotech2024 highlighting the importance of Australia’s 1st National Biotech & Medtech Development & Commercialisation Summit, coming up in Canberra on 19 Nov 2024. Let's supercharge the 'D' in R&D!

Great to have some of our team taking part in the @program_bridge Symposium in Melbourne - which aims to boost the commercial outputs of Australian pharmaceutical research. MTPConnect SA's @DanaBell22 shared her insights on making industry connections with the cohort.

Delighted to be hosting the Korean delegation of health officials in Sydney and Melbourne for meetings and site visits this week ahead of #AusBiotech24, working with @Austrade. Building on our connection with Korean Health Industry Development Institute! 🫶

Excited to be part of this new program to equip early career researchers with commercialisation know-how & opportunities to partner with industry on medical innovations - so more make it from the lab to the patient. Our COO Lisa Dubé joined Hon. Natalie Hutchins MP at the launch!.

We’re delighted to host the Korean delegation to @AusBiotech! The delegates visited @RandwickHealth in Sydney for site visits & presentations on genomics & cancer research. Korea is an increasingly important market & and hub for the #lifesciences sector in Australia. 🇦🇺🇰🇷👏🏼👏🏻🧪🧬

📢New case study! A #REDI Fellowship brought researcher Dr Emma Sweeney together with molecular diagnostic company @speedx, to develop new precision medicine treatment strategies for sexually transmitted superbug Mycoplasma genitalium. Find out more🧪

👏Congratulations to @CORTICAL10, @MicrobioAus , and Resonait Medical Technologies for being selected for the new Biomedical AI Sprints Accelerator established by @ARMHubAus & @MTPConnect_AUS .More info. bit.ly/3UlcJze